Prognostic Impact of Serum Homocysteine-Lowering Therapy on Patients with Hemorrhagic Stroke and Its Influence on National Institutes of Health Stroke Scale and China Stroke Scale Scores

CONCLUSIONS: High-dose folic acid, methylcobalamin, and vitamin B6 as part of serum homocysteine-lowering therapy can improve oxidative stress and vascular endothelial function in HS patients. This treatment also enhances prognosis and ameliorates neurological deficits. Therefore, it holds significant clinical potential and should be considered for broader adoption.PMID:37793337

Source: Alternative Therapies in Health and Medicine - October 4, 2023 Category: Complementary Medicine Authors: Xiangyang An Xinrui Du Bo Yang Naichi Zhai Laixian Cui Source Type: research